Skip to main content
CTRE
NYSE Real Estate & Construction

CareTrust Finalizes 19.55M-Share Forward Offering at $37.50, $36.00 Forward Price

Arie Shkolnikov · Analysis by Wiseek AI
More coverage: REIT Stocks · Real Estate
Sentiment info
Negative
Importance info
7
Price
$38.07
Mkt Cap
$9.809B
52W Low
$34.74
52W High
$43.62
52W Position info
9.6% above low
Off High info
13% below high
Rel. Volume info
1.1× avg
Market data snapshot near publication time

CTRE is trading near its 52-week low of $34.74 (9.6% above the low).

Summary

CareTrust upsized and finalized its forward offering to 19,550,000 shares at a $37.50 public price and $36.00 initial forward price, raising roughly $704 million of eventual proceeds to fund acquisitions.


Key Events · Financing and Capital Events · CTRE

  • Forward Offering Finalized at 19.55M Shares

    Underwriters bought 17,000,000 firm shares and exercised in full their option for 2,550,000 more, for 19,550,000 shares total at a $37.50 public offering price.

  • Roughly $704M of Eventual Proceeds

    Initial forward sale price is $36.00 per share; 19,550,000 x $36.00 = about $704 million payable to CareTrust on physical settlement, before daily rate adjustments and quarterly $0.39 dividend reductions.

  • Settlement Due by November 2027

    CareTrust expects to settle the Forward Sale Agreements by delivering new shares on dates it specifies no later than November 12, 2027; it retains the right to elect cash or net share settlement.

  • Capital Earmarked for Acquisition Pipeline

    Proceeds support the recently closed $400 million skilled-nursing portfolio purchase and the £1.1 billion UK care-home acquisition, against $2.075 billion of total debt reported in the Q3 10-Q.


Analysis · CTRE · Real Estate & Construction

CareTrust locked in a large equity raise through forward sale agreements rather than an immediate share sale: the dealers borrowed and sold 19,550,000 existing shares at $37.50, and CareTrust will issue new shares to settle the forwards by November 12, 2027 in exchange for roughly $36.00 per share before adjustments. That is about $704 million of eventual proceeds at the initial forward price, capital that funds the acquisition pipeline (the $400 million skilled-nursing portfolio and the £1.1 billion UK care-home deal) without adding debt on top of the $2.075 billion already on the balance sheet. The cost is real dilution — 19.55 million new shares against a company with a roughly $9.8 billion market value — and the forward structure means the share count rises when CareTrust settles, not today. The full exercise of the greenshoe shows demand held at pricing.

How filings like this one have moved

In the 30 days to Nov 12, 2026, 37% of the 3595 measured filings Wiseek scored 7 moved their stock by 5% or more by the next session's close. The median move was 0.00%. These are measured outcomes after filings of this importance, not a forecast for this one.

Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset

At the time of this filing, CTRE was trading at $38.07 on NYSE in the Real Estate & Construction sector, with a market capitalization of approximately $9.8B. The 52-week trading range was $34.74 to $43.62. This filing was assessed with negative market sentiment and an importance score of 7 out of 10.

View Main SEC Filing

Price Chart

Share this article

Copied!

CTRE - Latest Insights

CTRE
Nov 12, 2026, 12:30 AM EST
Source: BusinessWire
Importance Score:
7
Price at Filing: $37.52
Real-time Price: $38.07 info
Change: +$0.5505 (+1%) info
Market Cap: $9.809B info
CTRE
Nov 11, 2026, 4:37 PM EST
Source: BusinessWire
Importance Score:
8
Price at Filing: $39.04
Real-time Price: $38.07 info
Change: -$0.970 (-2%) info
Market Cap: $9.809B info
CTRE
Nov 05, 2026, 4:12 PM EST
Source: Dow Jones Newswires
Importance Score:
7
Price at Filing: $37.18
Real-time Price: $38.07 info
Change: +$0.890 (+2%) info
Market Cap: $9.809B info
CTRE
Nov 05, 2026, 4:09 PM EST
Filing Type: 8-K
Importance Score:
7
Price at Filing: $37.18
Real-time Price: $38.07 info
Change: +$0.890 (+2%) info
Market Cap: $9.809B info
CTRE
Nov 05, 2026, 4:07 PM EST
Filing Type: 10-Q
Importance Score:
7
Price at Filing: $37.18
Real-time Price: $38.07 info
Change: +$0.890 (+2%) info
Market Cap: $9.809B info